# Long-Term PEA Safety Study

> **NCT06717867** · PHASE2 · RECRUITING · sponsor: **RDC Clinical Pty Ltd** · enrollment: 200 (estimated)

## Conditions studied

- Healthy
- Safety

## Interventions

- **DIETARY_SUPPLEMENT:** Palmitoylethanolamide (PEA)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06717867
- **Lead sponsor:** RDC Clinical Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-22
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06717867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06717867, "Long-Term PEA Safety Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06717867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*